Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-05 09:00 am Sale | 2026-03-04 | 13D | Ventyx Biosciences, Inc. VTYX | Subramaniam Somu | 0 0.000% | -4,122,975 (Position Closed) | Filing History |
| 2026-02-19 4:06 pm Purchase | 2026-02-12 | 13G | Ventyx Biosciences, Inc. VTYX | Glazer Capital, LLC | 4,446,004 6.230% | 4,446,004 (New Position) | Filing History |
| 2026-02-06 4:13 pm Sale | 2026-01-31 | 13G | Ventyx Biosciences, Inc. VTYX | MORGAN STANLEY MS | 237,358 0.300% | -4,052,557 (-94.47%) | Filing History |
| 2026-02-05 4:53 pm Purchase | 2025-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | MORGAN STANLEY MS | 4,289,915 6.000% | 4,289,915 (New Position) | Filing History |
| 2026-01-29 7:59 pm Purchase | 2026-01-22 | 13G | Ventyx Biosciences, Inc. VTYX | Affinity Asset Advisors LLC | 6,465,041 9.000% | 2,407,936 (+59.35%) | Filing History |
| 2026-01-09 9:48 pm Purchase | 2026-01-07 | 13D | Ventyx Biosciences, Inc. VTYX | Subramaniam Somu | 4,122,975 5.800% | 4,122,975 (New Position) | Filing History |
| 2026-01-09 9:48 pm Purchase | 2026-01-07 | 13D | Ventyx Biosciences, Inc. VTYX | Mohan Raju | 4,387,682 6.000% | 5,322 (+0.12%) | Filing History |
| 2025-11-26 7:28 pm Purchase | 2025-11-26 | 13D | Ventyx Biosciences, Inc. VTYX | Mohan Raju | 4,382,360 6.000% | 4,382,360 (New Position) | Filing History |
| 2025-11-14 4:07 pm Sale | 2025-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 3,209,645 4.500% | -2,685,424 (-45.55%) | Filing History |
| 2025-10-31 11:30 am Purchase | 2025-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | The Vanguard Group | 3,769,997 5.280% | 302,276 (+8.72%) | Filing History |
| 2025-08-14 4:58 pm Purchase | 2025-06-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 5,895,069 8.300% | 1,494,744 (+33.97%) | Filing History |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Ventyx Biosciences, Inc. VTYX | BlackRock Inc. BLK | 1,350,987 1.900% | -2,463,544 (-64.58%) | Filing History |
| 2025-05-30 7:01 pm Purchase | 2025-05-22 | 13G | Ventyx Biosciences, Inc. VTYX | Affinity Asset Advisors LLC | 4,057,105 5.700% | 4,057,105 (New Position) | Filing History |
| 2025-05-15 5:29 pm Sale | 2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX | Citadel Advisors LLC | 1,409,601 2.000% | -2,869,952 (-67.06%) | Filing History |
| 2025-05-15 1:10 pm Sale | 2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX | BANK OF AMERICA CORP BAC | 1,016,649 1.400% | -3,599,887 (-77.98%) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX | Sio Capital Management LLC | 2,582,655 3.630% | -1,464,142 (-36.18%) | Filing History |
| 2025-04-01 9:40 pm Purchase | 2025-03-28 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Partners III, L.P. | 4,089,975 5.700% | 4,089,975 (New Position) | Filing History |
| 2025-03-12 4:05 pm Sale | 2025-03-10 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 5,425,425 7.600% | -1,677,544 (-23.62%) | Filing History |
| 2025-02-14 6:09 pm Purchase | 2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | BANK OF AMERICA CORP BAC | 4,616,536 6.500% | 4,616,536 (New Position) | Filing History |
| 2025-02-13 08:59 am Sale | 2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | James E. Flynn | 534,737 0.760% | -6,180,764 (-92.04%) | Filing History |